Latin America gears up for major malaria drive
This article was originally published in Clinica
Executive Summary
The Pan American Health Organization (PAHO/OPS) is preparing to publish its blueprint for the control of malaria in Latin America and the Caribbean over the next five years, in which access to diagnostics will have a central role. So said Keith Carter, PAHO advisor on malaria, ahead of next week's executive committee meeting (Washington, September 25-29).
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.